You are here: Industry Insights > WuXi XDC

News List

WuXi XDC and LegoChem Ink ADC Agreement contractpharma
June 15, 2021
WuXi XDC, a global CDMO providing end-to-end bioconjugates services, and LegoChem Biosciences (LCB), signed a Memorandum of Understanding (MOU) for a partnership in development and manufacturing of antibody-drug conjugates (ADCs).
WuXi XDC and LegoChem sign MoD to make more ADCs accessible to patients cphi-online
June 15, 2021
XDC will provide a full range of development and manufacturing services in one centralised region
WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates firstwordpharma
June 10, 2021
WuXi XDC today announced that a Memorandum of Understanding (MOU) was signed to form a strategic partnership in development and manufacturing of antibody-drug conjugates (ADCs).
WuXi Biologics, WuXi STA Establish WuXi XDC JV contractpharma
May 17, 2021
WuXi Biologics and WuXi STA, a subsidiary of WuXi AppTec, established a joint venture company named WuXi XDC to provide contract development and manufacturing of bioconjugates including antibody-drug conjugates (ADCs). Dr. Jimmy (Jincai) Li was ...
WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services prnasia
May 14, 2021
WuXi Biologics, a global company with leading open-access biologics technology platforms, and WuXi STA, a subsidiary of WuXi AppTec, today announced that a joint venture company named WuXi XDC was established to provide end-to-end contract development ...